Lung cancer is one of the most common, most dangerous, and most frequently talked about forms of cancer in the world. Of all ...

A mathematical model shows that mutations that recur even modestly among cancer patients are cancer driving nucleotides that can be exhaustively identified to serve as targets of cancer therapy.

The following is a summary of “Research Trends of Artificial Intelligence in Lung Cancer: A Combined Approach of Analysis ...

Antibody-drug conjugates (ADCs) represent a promising cancer treatment modality designed to deliver highly potent cytotoxic ...

Essentially, what Concr demonstrates is that training their algorithms on smaller, yet more diverse, data can lead to increased accuracy, due to the broader biological variability within that training ...

About 70 percent of obese people have metabolic dysfunction-associated steatotic liver disease (MASLD). However, MASLD is also found in lean people. Paradoxically, some effective pharmacological ...

Dan G. Duda, DMD, PhD, of the Edwin L. Steele Laboratories for Tumor Biology and Department of Radiation Oncology at Massachusetts General Hospital, is the corresponding author of a paper published in ...

Multicancer early detection testing results in extended life-years and reduced cancer treatment costs through earlier diagnosis, leading to a cost-effective option in cancer screening.

The global cancer biopsy market is set to experience robust growth, with a market size of USD 25.5 billion in 2023, according ...

Sabari, MD, which focused on the approval of amivantamab plus lazertinib in the first line, he looks ahead to potential uses ...

Patients living with emphysema experience shortness of breath because areas within the lungs are diseased and are holding trapped air (hyperinflation of the lung). This makes it difficult to inhale ...